Effects of Carnosine on Alzheimer's Disease in Mice
Author Information
Author(s): Corona Carlo, Frazzini Valerio, Silvestri Elena, Lattanzio Rossano, La Sorda Rossana, Piantelli Mauro, Canzoniero Lorella M. T., Ciavardelli Domenico, Rizzarelli Enrico, Sensi Stefano L.
Primary Institution: University “G. d'Annunzio”, Chieti-Pescara, Italy
Hypothesis
Carnosine supplementation may reduce mitochondrial dysfunction and amyloid pathology in a mouse model of Alzheimer's disease.
Conclusion
Carnosine supplementation reduces intraneuronal amyloid deposition and restores mitochondrial function but does not significantly improve cognitive deficits in treated mice.
Supporting Evidence
- Carnosine supplementation significantly reduced intraneuronal Aβ accumulation in the hippocampus.
- Carnosine restored mitochondrial function in 3xTg-AD mice.
- Cognitive performance showed a positive trend but did not reach statistical significance.
Takeaway
Carnosine is a substance that might help with some problems in the brain caused by Alzheimer's, but it doesn't completely fix memory issues.
Methodology
The study used 3xTg-AD mice and assessed the effects of dietary carnosine supplementation on amyloid pathology, mitochondrial function, and cognitive performance using the Morris Water Maze test.
Limitations
The study did not address tau pathology, which may limit the cognitive benefits of carnosine supplementation.
Participant Demographics
Male 3xTg-AD mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website